Aligning Preclinical Decisions with FDA Expectations

Successful clinical development begins long before the first patient is enrolled. This webinar offers a deep dive into the legal and regulatory strategies essential for optimizing a preclinical development program. Hear best practices on how to design studies that meet FDA standards, avoid costly delays at the IND stage, and leverage early engagement through pre-IND meetings to de-risk your regulatory path. We’ll also explore how foundational decisions made in the lab can shape the trajectory of clinical trial planning and influence regulatory approval outcomes.

REGISTER»

Hosted by: